CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.620
+0.040 (1.55%)
Oct 6, 2026, 11:54 AM EDT - Market open
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $570.9 million as of October 6, 2026. Its market cap has increased by 4.91% in one year.
Market Cap
570.90M
Enterprise Value
246.32M
1-Year Change
4.91%
Ranking
Category
Stock Price
$2.62
ChartMarket Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $570.90M, an increase of 7,614.81%. That is a compound annual growth rate of 48.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 570.90M | -20.91% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 593.24M |
| YD Bio | 574.44M |
| CorMedix | 560.42M |
| Phathom Pharmaceuticals | 549.66M |
| MapLight Therapeutics | 545.75M |
| Valneva SE | 540.23M |
| Oculis Holding AG | 538.92M |
| Altimmune | 532.01M |